Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.
暂无分享,去创建一个
M. McDevitt | C. O'keefe | J. Maciejewski | R. Paquette | M. Sekeres | S. Kojima | H. Makishima | H. Muramatsu | E. Hsi | J. Huh | R. Tiu | H. Szpurka | A. List | A. Dunbar | Heather Cazzolli
[1] J. Maciejewski,et al. UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation , 2009, Leukemia.
[2] M. McDevitt,et al. 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies. , 2008, Cancer research.
[3] B. Löwenberg,et al. Exon 8 splice site mutations in the gene encoding the E3-ligase CBL are associated with core binding factor acute myeloid leukemias , 2008, Haematologica.
[4] P. Aplan,et al. Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl. , 2008, Blood.
[5] G. Mufti,et al. Whole genome scanning as a cytogenetic tool in hematologic malignancies. , 2008, Blood.
[6] K. Mrózek,et al. Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype. , 2008, Seminars in oncology.
[7] T. Haferlach,et al. Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype , 2008, Leukemia.
[8] Axel Benner,et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. , 2008, The New England journal of medicine.
[9] C. O'keefe,et al. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. , 2008, Blood.
[10] N. Shinton. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues , 2007 .
[11] M. McDevitt,et al. SNP Array Karyotyping Allows for the Detection of Uniparental Disomy and Cryptic Chromosomal Abnormalities in MDS/MPD-U and MPD , 2007, PloS one.
[12] G. Mufti,et al. Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes. , 2007, Blood.
[13] C. O'keefe,et al. Single nucleotide polymorphism arrays complement metaphase cytogenetics in detection of new chromosomal lesions in MDS , 2007, Leukemia.
[14] M. Caligiuri,et al. Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia. , 2007, Blood.
[15] Chunaram Choudhary,et al. Flt3-dependent transformation by inactivating c-Cbl mutations in AML. , 2007, Blood.
[16] J. Maciejewski,et al. Bone Marrow Phospho-STAT5 Expression in Non-CML Chronic Myeloproliferative Disorders Correlates With JAK2 V617F Mutation and Provides Evidence of In Vivo JAK2 Activation , 2007, The American journal of surgical pathology.
[17] A. Tsygankov,et al. The Cbl family proteins: Ring leaders in regulation of cell signaling , 2006, Journal of cellular physiology.
[18] J. Maciejewski,et al. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation. , 2006, Blood.
[19] Sandra A. Moore,et al. MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia , 2006, PLoS medicine.
[20] W. Hiddemann,et al. 1 KIT-D 816 mutations in AML 1-ETO positive AML are associated with impaired event-free and overall survival , 2005 .
[21] S. Fröhling,et al. Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7. , 2006, Blood.
[22] Ivan Dikic,et al. The Cbl interactome and its functions , 2005, Nature Reviews Molecular Cell Biology.
[23] Pawel Stankiewicz,et al. Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed Phenotypes , 2005, PLoS genetics.
[24] Mario Cazzola,et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. , 2005, The New England journal of medicine.
[25] Sandra A. Moore,et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. , 2005, Cancer cell.
[26] P. Campbell,et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders , 2005, The Lancet.
[27] L. Feuk,et al. Detection of large-scale variation in the human genome , 2004, Nature Genetics.
[28] D. Bowtell,et al. Tissue Hyperplasia and Enhanced T-Cell Signalling via ZAP-70 in c-Cbl-Deficient Mice , 1998, Molecular and Cellular Biology.
[29] W. Langdon,et al. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. , 1991, Oncogene.
[30] D. Gilliland. Hematologic malignancies. , 2001, Current opinion in hematology.